As we look ahead, it is our intention to build on our success. Backed by the experience of a highly skilled and dedicated workforce, ROWEX Ltd. will continue to introduce quality, innovative, cost-effective medicines.
Sandoz, trading as Rowex, is one of Ireland’s leading providers of biosimilar and generic pharmaceuticals. We exercise a strong commitment to the local community, sponsoring projects such as the Bantry Hospice project and the Matt Kingston Third level Scholarship. Established in 1993, Rowex is committed to providing high quality products which are available to all your patients.
Building on a legacy of a successful 30-year joint venture in Ireland with Rowa Pharmaceuticals, in 2024 Sandoz acquired the remaining shares in Rowex. Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are present in more than 100 countries and our medicines serve some 500 million people every year.
Mission
Strategy
Our strategy is to retain and attract new customers. The customer is at the centre of everything we do. We go beyond traditional generic products, finding pragmatic and innovative ways to make even the most complex medicines affordable and accessible to everyone. We want our high-quality and differentiated medicines to add value to patient healthcare and improve their quality of life.
Commitment
ROWEX Ltd. is committed to providing excellent service and support to the company’s Irish customers. This is sustained by a full complement of a medical sales team to satisfy the requirements of both the medical profession and pharmacists.
Investment
ROWEX Ltd. is renowned for its high-quality products which are competitively priced and further strengthened by continuous investment in the development and registration of new products.
THE CUSTOMER
The customer is at the centre of everything we do. We go beyond traditional generic products, finding pragmatic and innovative ways to make even the most complex medicines affordable and accessible to everyone. We want our high-quality and differentiated medicines to add value to patient healthcare and improve their quality of life.
